Many learners are more facile with the use of large language models in medicine than their supervisors are. The authors ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...

A 32-year-old woman presented with fatigue, myalgias, and palpitations. The cardiac rhythm was irregularly irregular, and an electrocardiogram showed findings suggestive of grouped beating. A diagn ...

Methods In this phase 3, double-blind, placebo-controlled trial, we randomly assigned patients with aPAP to receive molgramostim at a dose of 300 μg or placebo once daily for 48 weeks. The ...

THE diagnosis of massive pulmonary embolism is frequently difficult and always uncertain, primarily because the symptoms and signs may mimic those of some other diseases, such as myocardial infarct ...

In this randomized trial, the inhaled recombinant human GM-CSF molgramostim improved pulmonary gas transfer in patients with autoimmune pulmonary alveolar proteinosis.

High-risk cutaneous squamous-cell carcinoma has a substantial risk of recurrence after surgery and radiotherapy. New research findings on adjuvant cemiplimab therapy are summarized in a short video.

In resectable lung cancer, neoadjuvant nivolumab plus chemotherapy improved 5-year overall survival, with no lung cancer deaths reported at 5 years in patients with a pathological complete response.

In this trial involving women taking endocrine therapy for HR-positive breast cancer, elinzanetant (a neurokinin-targeted therapy) significantly reduced the frequency of moderate- ...